You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

If you can convince the FDA commissioner to immerse himself in a tub of very cold water, then you deserve the title of “influencer.” Send uncomfortable wellness advice and news tips to [email protected] or John_Wilkerson.07 on Signal.

Trials and tribulations

The FDA plans to require just one clinical trial, instead of two, for medical product approvals, according to Commissioner Marty Makary, who spoke exclusively with my colleague Lizzy Lawrence about the plan.

To read the rest of this story subscribe to STAT+. Subscribe Log In

See Full Page